4.7 Review

The Biological Functions and Clinical Applications of Integrins in Cancers

Journal

FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.579068

Keywords

integrins; cancer metastasis; drug resistance; stemness; extracellular matrix; therapeutic targeting

Funding

  1. National Natural Science Foundation of China [U1903126, 81773888, 81902152]
  2. Natural Science Foundation of Guangdong Province [2020A151501005, 2020A1515010605]
  3. Fund from Guangzhou Institute of Pediatrics/Guangzhou Women and Children's Medical Center [YIP-2018-031, IP-2018-012]

Ask authors/readers for more resources

Integrins are the adhesion molecules and receptors of extracellular matrix (ECM). They mediate the interactions between cells-cells and cells-ECM. The crosstalk between cancer cells and their microenvironment triggers a variety of critical signaling cues and promotes the malignant phenotype of cancer. As a type of transmembrane protein, integrin-mediated cell adhesion is essential in regulating various biological functions of cancer cells. Recent evidence has shown that integrins present on tumor cells or tumor-associated stromal cells are involved in ECM remodeling, and as mechanotransducers sensing changes in the biophysical properties of the ECM, which contribute to cancer metastasis, stemness and drug resistance. In this review, we outline the mechanism of integrin-mediated effects on biological changes of cancers and highlight the current status of clinical treatments by targeting integrins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available